Log out

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201.

Antero Resources Corp (AR)

$4.30 0.26 (6.31%)

12:40 EDT AR Stock Quote Delayed 30 Minutes

Volume:

Previous Close $4.04

Market Cap 1.36B

PE Ratio 3.77

EPS 1.14

Volume (Avg. Vol.) 7.32M

Day's Range 4.03 - 4.38

52-Week Range 0.64 - 4.41

Dividend & Yield N/A (N/A)

AR Stock Predictions, Articles, and Antero Resources Corp News

From the Web

Russia Registered a Coronavirus Vaccine. The Market Loves It.

From Barron's Aug 11, 2020

The vaccine has been tested on animals and two groups of 38 humans each, far fewer than is required for approval of a drug by the FDA.

The Rally Broadens, Dow Theory, Virus Cocktail, 4 Questions: Market Recon

From Real Money Aug 11, 2020

Markets may believe that we are closer to the effective use of vaccines and therapeutics than we know in this battle against Covid-19.

Inovio Coronavirus Vaccine To Enter Mid-To-Late Stage Testing In September

From Benzinga Aug 11, 2020

Inovio Pharmaceuticals Inc (NASDAQ: INO) said during the earnings call Monday it expected its COVID-19 vaccine to enter mid-to-late stage human trials in September, Reuters...

Moderna COVID Vaccine Still Has 'Best-In-Class Potential,' Says Barclays

From Talk Markets Aug 6, 2020

Barclays analyst Gena Wang raised the firm's price target on Moderna to $84 from $68 and keeps an Overweight rating on the shares.

Rocket Reversals

From Talk Markets Aug 10, 2020

Over the last few days, we’ve been seeing a moderate rotation in the market as red-hot growth stocks sell-off and investors shift into other areas of the market that have been lagging.

5 Stocks in the Spotlight on Trump's Coronavirus Vaccine Optimism

From Zacks Investment Research Aug 10, 2020

Millions are pinning their hopes on a handful of drugmakers, which are into the final phases of their vaccine trial.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold